Advertisement

Transcriptional and Post-Transcriptional Regulation of the Human IGF-II Gene Expression

  • J. S. Sussenbach
  • R. J. T. Rodenburg
  • W. Scheper
  • P. Holthuizen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 343)

Summary

The human insulin-like growth factor II (IGF-II) gene consists of nine exons and has four promoters (P1–4). The promoters exhibit a tissue-specific and developmental stage-dependent expression pattern. In fetal liver promoters P2–4 are expressed, but after birth these promoters are shut off and another promoter, P1, is activated.

We have investigated some properties of the human promoters P1 and P3 and identified a number of sequence elements, that are recognized by transcription factors. Promoter PI is stimulated by the liver-enriched transcription factors C/EBP and LAP, whereas in the proximal region of P3 we have identified several elements that are recognized by transcription factors, including krox20/egr2 and krox24/egrl.

Besides transcriptional regulation of expression also regulation at the post-transcriptional level occurs. We have found that the IGF-II mRNAs are subjected to site-specific endonucleolytic cleavage yielding a labile 5’ specific fragment and a stable polyadenylated 3’ specific cleavage product of 1.8 kb. Two widely separated sequence elements within the last exon were identified that are able to interact and yield a double-stranded stem structure. It is likely that this structure is essential for post-transcriptional cleavage of IGF-II mRNAs.

Keywords

Electrophoretic Mobility Shift Assay Hep3B Cell Endonucleolytic Cleavage Electrophoretic Mobility Shift Analysis Cleavage Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Birkenmeier, E.H., Gwynn, B., Howard, S., Jerry, J., Gordon, J.I., Landschulz, W.H. and McKnight S.L.,1989, Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein, Genes Dev. 3:1146.PubMedCrossRefGoogle Scholar
  2. Descombes, P. and Schibler, U., 1991, A liver-enriched íranscriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA, Cell ,67:569.PubMedCrossRefGoogle Scholar
  3. De Pagter-Holthuizen, P., Jansen, M., Van Schaik, F.M.A., van der Kammen, R.A., Oosterwijk, C, Van den Brande, J.L. and Sussenbach, J.S., 1987, The human insulin-like growth factor II contains two development-specific promoters, FEBS Lett. 214:259.PubMedCrossRefGoogle Scholar
  4. De Pagter-Holthuizen, P., Jansen, M., van der Kammen, R.A., Van Schaik, F.M.A. and Sussenbach, J.S., 1988, Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-n mRNAs and an mRNA encoding a putative IGF-H-associated protein, Biochim. Biophys. Acta 950:282.PubMedCrossRefGoogle Scholar
  5. Drammond, I.A., Madden, S.L., Rohwer-Nutter, P., Bell, G.I., Sukhatme, VP. and Rauscher III, F.J., 1992, Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1, Science, 257:674.CrossRefGoogle Scholar
  6. Haselbacher, G.K., Irminger, J.C., Zapf, J., Ziegler, W.H. and Humbel, R.E., 1987, Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumours: expression at the mRNA and protein level, Proc. Natl. Acad. Sci. USA ,84:1104.PubMedCrossRefGoogle Scholar
  7. Holthuizen, P., van der Lee, F.M., Ikejiri, K., Yamamoto, M. and Sussenbach, J.S., 1990, Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene, Biochim. Biophys. Acta 1087:341.PubMedCrossRefGoogle Scholar
  8. Johnson, P.F., Landschulz, W.H., Graves, B.J. and McKnight, S.L, 1987, Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses, Genes Dev. ,1:133.PubMedCrossRefGoogle Scholar
  9. Landschulz, W.H., Johnson, P.F., Adashi, E.Y., Graves, BJ. and McKnight, S.L., 1988, Isolation of a recombinant copy of the gene encoding C/EBP, Genes Dev. 2:786.PubMedCrossRefGoogle Scholar
  10. Landschulz, W.H., Johnson, P.F. and McKnight, S.L., 1989, The DNA binding domain of the rat liver nuclear factor C/EBP is bipartite, Science 243:1681.PubMedCrossRefGoogle Scholar
  11. Lemaire, P., Relevant, O., Bravo, R., and Charnay, P., 1988, Two mouse genes encoding potential transcription factors with identical DNA binding domains are activated by growth factors in cultured cells, Proc. Nad. Acad. Sci. USA 85:4691.CrossRefGoogle Scholar
  12. Lemaire, P., Vesque, C., Schnitt, J., Stunnenberg, H., Frank, R. and Charnay, P., 1990, The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator, Mol. Cell. Biol. 10:3456.PubMedGoogle Scholar
  13. Madden, S.L., Cook, D.M., Morris, J.F., Gashler, A., Subhatme, V.P. and Rauscher-III, F.J., 1991, Transcriptional repression mediated by the WT1 Wilms tumor gene product, Science 253:1550.PubMedCrossRefGoogle Scholar
  14. Meinsma, D., Holthuizen, P., Van den Brande, J.L. and Sussenbach, J.S., 1991, Specific endonucleolytic cleavage of IGF-H mRNAs, Biocnem. Biophys. Res. Commun. 179:1509.CrossRefGoogle Scholar
  15. Meinsma, D., Scheper, W., Holthuizen, P., Van den Brande, J.L. and Sussenbach, J.S., 1992, Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-H gene, Nucleic Acids Res. 20:5003.PubMedCrossRefGoogle Scholar
  16. Paik, S., Rosen, N., Jung, W., You, J.M., Lippman, M.E., Perdue, J.F. and Yee, D., 1989, Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms’ tumor. An in situ hybridization study, Lab. Invest. 61:522.PubMedGoogle Scholar
  17. Rauscher-m, F.J., Morris, J.F., Tournay, O.E., Cook, D.M. and Curren, T., 1990, Binding of the Wilms* tumor locus zinc finger protein to the EGR-1 consensus sequence, Science 250:1259.CrossRefGoogle Scholar
  18. Ryden, T.A. and Beemon, K., 1989, Avian retroviral long terminal repeats bind CCAAT/Enhancer binding protein, Mol. Cell. Biol. 9:1155.PubMedGoogle Scholar
  19. van Dijk, M.A., Van Schaik, F.M.A., Bootsma, H.J., Holthuizen, P. and Sussenbach, J.S., 1991, Initial characterization of the four promoters of the human IGF-II gene, Mol. Cell. Endocrinol. 81:81.PubMedCrossRefGoogle Scholar
  20. van Dijk, M.A., Rodenburg, R.J.T., Holthuizen, P. and Sussenbach, J.S., 1992, The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP), Nucleic Acids Res. 20:3099.PubMedCrossRefGoogle Scholar
  21. Zuker, M. and Stiegler, P., 1981, Optimal computerfolding of large RNA sequences using thermodynamics and auxiliary information, Nucleic Acids Res. 18:3035.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • J. S. Sussenbach
    • 1
  • R. J. T. Rodenburg
    • 1
  • W. Scheper
    • 1
  • P. Holthuizen
    • 1
  1. 1.Laboratory for Physiological ChemistryUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations